Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 4/2023

Open Access 08-12-2022 | Stroke | Commentary

A tale of flawed e-cigarette research undetected by defective peer review process

Authors: Riccardo Polosa, Konstantinos Farsalinos

Published in: Internal and Emergency Medicine | Issue 4/2023

Login to get access

Excerpt

Research on tobacco harm reduction (THR), and particularly on electronic cigarettes (e-cigarettes), remains a highly controversial topic in the scientific community. The controversy is also sustained by research, which is often poorly designed, conducted, and interpreted [1]. Dissemination of inaccurate information on smoke-free alternatives in the media contributes to public skepticism and uncertainty, particularly among smokers, who as a result are discouraged from adopting reduced-risk lifestyles. …
Literature
1.
Hajat C, Stein E, Selya A, Polosa R, CoEHAR study group (2022) Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research. Intern Emerg Med 17(3):887–909CrossRefPubMedPubMedCentral
2.
Parekh T, Pemmasani S, Desai R (2020) Risk of stroke with e-cigarette and combustible cigarette use in young adults. Am J Prev Med 58(3):446–452CrossRefPubMed
3.
Farsalinos K, Abrams D, Niaura R (2020) Can the association between electronic-cigarette use and stroke be interpreted as risk of stroke? Am J Prev Med 58(6):895–896CrossRefPubMed
4.
5.
6.
Metadata
Title
A tale of flawed e-cigarette research undetected by defective peer review process
Authors
Riccardo Polosa
Konstantinos Farsalinos
Publication date
08-12-2022
Publisher
Springer International Publishing
Keyword
Stroke
Published in
Internal and Emergency Medicine / Issue 4/2023
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03163-x

Other articles of this Issue 4/2023

Internal and Emergency Medicine 4/2023 Go to the issue

CE-Systematic reviews and meta-analysis

Incidence and outcomes of pancreatic encephalopathy in patients with acute pancreatitis: a systematic review and meta-analysis

IM - REVIEW

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care

CE-Research Letter to the Editor

Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis

IM - ORIGINAL

Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia

IM - ORIGINAL

Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

IM - ORIGINAL

Controlling nutritional status score predicts 2-year outcomes in elderly patients admitted for acute heart failure
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits